首页> 外文OA文献 >Synthesis of novel benzenesulfamide derivatives with inhibitory activity against human cytosolic carbonic anhydrase I and II and Vibrio cholerae α- and β-class enzymes
【2h】

Synthesis of novel benzenesulfamide derivatives with inhibitory activity against human cytosolic carbonic anhydrase I and II and Vibrio cholerae α- and β-class enzymes

机译:具有抑制抑制人胞质胞质碳酸酐酶I和II的新型苯磺胺酰胺衍生物的新苯磺胺酰胺衍生物及β级α-和β级酶

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The synthesis of a new series of sulfamides incorporating ortho-, meta, and para-benzenesulfamide moieties is reported, which were investigated for the inhibition of two human (h) isoforms of the zinc enzyme carbonic anhydrase (CA, EC 4.2.1.1), hCA I and II, and two Vibrio cholerae enzymes, belonging to the α- and β-CA classes (VchCAα, VchCAβ). The compounds were prepared by using the “tail approach”, aiming to overcome the scarcity of selective inhibition profiles associated to CA inhibitors belonging to the zinc binders. The built structure–activity relationship showed that the incorporation of benzhydryl piperazine tails on a phenyl sulfamide scaffold determines rather good efficacies against hCA I and VchCAα, with several compounds showing KIs < 100 nM. The activity was lower against hCA II and VchCAβ, probably due to the fact that the incorporated tails are quite bulky. The obtained evidences allow us to continue the investigations of different tails/zinc binding groups, with the purpose to increase the effectiveness/selectivity of such inhibitors against bacterial CAs from pathogens, affording thus potential new anti-infectives.
机译:报道了一种包含邻邻,Meta和对苯磺酰磺酰胺部分的新一系列磺胺族磺酰胺部分的合成,用于抑制锌酶碳酸酐酶(CA,EC 4.2.1.1)的两种人(H)同种型, HCA I和II,以及两种Vibrio Cholerae酶,属于α-和β-CA类(VCHCAα,VCHCAβ)。通过使用“尾气方法”制备化合物,旨在克服与属于锌粘合剂的Ca抑制剂相关的选择性抑制曲线的稀缺性。构建的结构 - 活性关系表明,苯磺酰胺支架上的苯甲酰哌嗪尾掺入苯磺酰胺支架上的含量与HCA I和VCHCAα的效果相当良好,其中几种化合物显示出KIS <100nm。对HCA II和VCHCAβ的活性可能降低,可能是由于掺入的尾巴非常笨重。所获得的证据允许我们继续对不同尾部/锌结合基团的调查,目的是提高这些抑制剂对来自病原体的细菌CA的效果/选择性,这是潜在的新抗感染性。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号